Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
PTC Inc. (NASDAQ:PTC ) Inc. Citi's 2025 Global Technology, Media and Telecommunications Conference September 4, 2025 12:50 PM EDT Company Participants Neil Barua - President, CEO & Director Kristian Talvitie - Executive VP & CFO Conference Call Participants Tyler Radke - Citigroup Inc., Research Division Presentation Tyler Radke VP & Senior Analyst Good afternoon everyone. Tyler Radke here.
PTC Inc. (PTC) possesses solid growth attributes, which could help it handily outperform the market.
Company is positioned for growth with SEPHIENCE, approved for PKU in the US and Europe, and pending decisions in Japan and Brazil. Votoplam (PTC518) for Huntington's Disease shows promising phase 2 results; a key FDA meeting in Q4 2025 could enable Accelerated Approval and set a phase 3 trial design. Strong partnership with Novartis provides financial strength and development support for votoplam for treatment of HD patients, with up to $1.9 billion in milestone payments possible.
ZWS, SHG and PTC made it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 18, 2025.
PTC Inc. (PTC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
PTC Inc. (PTC) is well positioned to outperform the market, as it exhibits above-average growth in financials.
PTC Inc. (PTC) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
PTC Inc. (NASDAQ:PTC ) Q3 2025 Earnings Conference Call July 30, 2025 5:00 PM ET Company Participants Kristian P. Talvitie - Executive VP & CFO Matthew Shimao - Senior Vice President of Investor Relations Neil Barua - President, CEO & Director Robert Dahdah - Executive VP & Chief Revenue Officer Conference Call Participants Adam Charles Borg - Stifel, Nicolaus & Company, Incorporated, Research Division Andrew Burris Obin - BofA Securities, Research Division Blair Harold Abernethy - Rosenblatt Securities Inc., Research Division Hoi-Fung Wong - Oppenheimer & Co. Inc., Research Division Jason Vincent Celino - KeyBanc Capital Markets Inc., Research Division Jay Vleeschhouwer - Griffin Securities, Inc., Research Division Joseph D.
The headline numbers for PTC Inc. (PTC) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
PTC Inc. (PTC) came out with quarterly earnings of $1.64 per share, beating the Zacks Consensus Estimate of $1.22 per share. This compares to earnings of $0.98 per share a year ago.